Table 1 Program and Session Facilitators
From: "Harnessing genomics to improve health in India" – an executive course to support genomics policy
| Time | Day 1 | Day 2 | Day 3 | Day 4 |
|---|---|---|---|---|
| 9:00 – 10:30 |
Introduction and Course Overview
Dr Vasantha Muthuswamy – ICMR Dr Peter A. Singer – University of Toronto Dr Abdallah S. Daar – University of Toronto |
Ethical guidelines for Medical Research in India
Dr N.K. Ganguly – ICMR |
Intellectual Property Rights
Dr Malathi Lakshmikumaran – TERI |
Opinion Leaders' Network
Dr Peter A. Singer Dr Rakesh Dubey – Ocimum Biosolutions |
| 11:00–12:30 |
New Science 1 : Genomics
Dr S. S. Agarwal – ACTREC DNA Vaccines – Relevance for India Dr G. Padmanabhan – IISc |
Business Models
Dr Chandu Nair – Scope Marketing & Knowledge National Systems of Innovation Dr Peter A. Singer |
Public Health – Community Ownership
Dr Saraswathi Sankaran – DESH | |
| 2:00–3:30 |
New Science 2 : Stem Cells
Dr Dipika Mohanty – ICMR (Institute of Immunohaematology) |
Indian Business Perspectives
Mr Khalil Ahmed – Shanta Biotech Dr Krishna Ella – Bharath Biotech |
Group Presentations
Biotechnology: From Benches to Bedside Dr Rajesh Behl – Centre for Human Genetics | Group Presentations |
| 4:00–5:30 |
Genomics and Global Health
Dr Abdallah S. Daar |
Pharmaco-genomics
Dr C. M. Gupta – CDRI Dr Vasantha Muthuswamy Dr R. H. Jani – German Remedies |
Legal Regulations of Genomics – Emerging Scenario
Dr Madhava Menon – WB National University of Juridical Sciences |
Summing up
Dr Sandhya Tewari – CII Discussion & Closing – Dr Peter A. Singer |
